AMANDA ANDERSON-PLEISS: Open Payments
NPI 1467045435 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,212 in 66 payments from 15 companies in 2025. Trend: 2023 $1,773 · 2024 $750 · 2025 $1,212
Food & beverage: $1,212
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 19 | $299 |
| AstraZeneca Pharmaceuticals LP | 13 | $264 |
| Regeneron Healthcare Solutions, Inc. | 11 | $174 |
| GlaxoSmithKline, LLC. | 10 | $168 |
| Grifols USA, LLC | 3 | $53 |
| HARMONY BIOSCIENCES LLC | 1 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| United Therapeutics Corporation | 1 | $27 |
Products named: DUPIXENT, NUCALA, FASENRA, TEZSPIRE, Prolastin-C Liquid, WAKIX, TRELEGY ELLIPTA, BREZTRI.
Industry payments across CO — which companies pay providers there.
